Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-02-12 4:24 pm Sale |
2023-12-31 | 13G | Freeline Therapeutics Holdings plc FRLN |
Integrated Core Strategies (US) LLC | 0 0.000% |
-5,555,085![]() (Position Closed) |
Filing History |
2024-02-09 4:11 pm Purchase |
2024-01-31 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
Integrated Core Strategies (US) LLC | 419,707 4.100% |
419,707![]() (New Position) |
Filing History |
2024-02-08 4:43 pm Purchase |
2023-12-31 | 13G | Vapotherm, Inc. VAPO |
Integrated Core Strategies (US) LLC | 490,044 7.800% |
490,044![]() (New Position) |
Filing History |
2024-02-08 4:36 pm Purchase |
2023-12-31 | 13G | Spyre Therapeutics, Inc. SYRE |
Integrated Core Strategies (US) LLC | 108,486 0.300% |
108,486![]() (New Position) |
Filing History |
2024-02-06 4:20 pm Sale |
2023-12-31 | 13G | CUTERA INC CUTRQ |
Integrated Core Strategies (US) LLC | 827,032 4.100% |
-663,040![]() (-44.50%) |
Filing History |
2024-02-05 4:32 pm Purchase |
2023-12-31 | 13G | flyExclusive, Inc. FLYX |
Integrated Core Strategies (US) LLC | 37,500 0.200% |
37,500![]() (New Position) |
Filing History |
2024-02-05 4:27 pm Purchase |
2023-12-31 | 13G | Longevity Health Holdings Inc. XAGE |
Integrated Core Strategies (US) LLC | 7,847 1.000% |
7,847![]() (New Position) |
Filing History |
2024-02-01 4:25 pm Sale |
2023-12-31 | 13G | MaxCyte, Inc. MXCT |
Integrated Core Strategies (US) LLC | 5,012,283 4.800% |
-758,611![]() (-13.15%) |
Filing History |
2024-01-31 4:32 pm Purchase |
2023-12-31 | 13G | Elevation Oncology, Inc. ELEV |
Integrated Core Strategies (US) LLC | 2,990,279 7.100% |
1,592,897![]() (+113.99%) |
Filing History |
2024-01-30 4:25 pm Sale |
2023-12-31 | 13G | TKB Critical Technologies 1 USCT |
Integrated Core Strategies (US) LLC | 0 0.000% |
-99,254![]() (Position Closed) |
Filing History |
2024-01-29 4:42 pm Sale |
2023-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
Integrated Core Strategies (US) LLC | 1,730,889 5.200% |
-464,140![]() (-21.15%) |
Filing History |
2024-01-29 4:36 pm Sale |
2023-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA |
Integrated Core Strategies (US) LLC | 132,674 4.900% |
-1,029![]() (-0.77%) |
Filing History |
2024-01-26 4:19 pm Sale |
2023-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH |
Integrated Core Strategies (US) LLC | 6,610 0.000% |
-981,102![]() (-99.33%) |
Filing History |
2024-01-25 4:09 pm Purchase |
2024-01-18 | 13G | Terns Pharmaceuticals, Inc. TERN |
Integrated Core Strategies (US) LLC | 3,479,630 5.600% |
3,479,630![]() (New Position) |
Filing History |
2024-01-24 4:16 pm Sale |
2023-12-31 | 13G | BioLife Solutions, Inc. BLFS |
Integrated Core Strategies (US) LLC | 2,412,650 5.400% |
-69,296![]() (-2.79%) |
Filing History |
2024-01-23 4:31 pm Sale |
2023-12-31 | 13G | Myriad Genetics, Inc. MYGN |
Integrated Core Strategies (US) LLC | 3,561,337 4.000% |
-699,704![]() (-16.42%) |
Filing History |
2024-01-22 4:15 pm Sale |
2023-12-31 | 13G | Twist Bioscience Corporation TWST |
Integrated Core Strategies (US) LLC | 1,821,238 3.200% |
-1,224,675![]() (-40.21%) |
Filing History |
2024-01-22 4:10 pm Sale |
2023-12-31 | 13G | SI-BONE, Inc. SIBN |
Integrated Core Strategies (US) LLC | 1,210,324 3.000% |
-1,066,163![]() (-46.83%) |
Filing History |
2024-01-22 4:07 pm Purchase |
2023-12-31 | 13G | Embecta Corp. EMBC |
Integrated Core Strategies (US) LLC | 3,635,948 6.300% |
467,043![]() (+14.74%) |
Filing History |
2024-01-19 4:32 pm Sale |
2023-12-31 | 13G | ZimVie Inc. ZIMV |
Integrated Core Strategies (US) LLC | 714,592 2.700% |
-763,832![]() (-51.67%) |
Filing History |